Aventis Articles
FDA OKs UCB/Sanofi's Xyzal for allergies
4 June 2007
Indian generic pressure for Sanofi's Acomplia
4 June 2007
FDA halts talabostat trials on efficacy concerns
28 May 2007
Stock Commentary - Europe - week to May 21, 2007
28 May 2007
Satraplatin delays pain progression to 66 weeks
28 May 2007
Sanofi Pasteur launches www.travel-vaccines.com
28 May 2007
FDA approves Lovenox sNDA for STEMI
28 May 2007
Stock Commentary - Europe - week to May 14, 2007
21 May 2007
French biotech firm claims grant bias
21 May 2007
B-MS resolves Plavix antitrust probe
21 May 2007
Pres-elect Sarkozy lifts pharma hopes in France
14 May 2007
FDA approves Sanofi's Lantus SoloStar
7 May 2007
Cimzia key drug in UCB 2007 R&D update
7 May 2007
Stock Commentary - Europe - week to April 23, 2007
30 April 2007
S-A launches APR's decongestant in Belgium
30 April 2007
Dr Reddy's launches generic zolpidem
30 April 2007
Clexane more effective than UFH in VTE
30 April 2007
Stock Commentary - Europe - week to April 16, 2007
23 April 2007
Japan stock market week to April 16, 2007
23 April 2007
FDA approves Novartis' Reclast for Paget's
23 April 2007
Surprise rise in German drug investment
23 April 2007
Major investment for Sanofi Pasteur
23 April 2007
Management changes at Sanofi-Aventis
16 April 2007
Stock Commentary - Europe - week to April 9
16 April 2007
Barr confirms Ambien patent challenge
16 April 2007
Record profits for Pharma in 2006
16 April 2007
Sanofi eyes Japan?
16 April 2007
UK
16 April 2007
Swissmedic approves Sanofi-Aventis' Acomplia
9 April 2007
EMEA restricts use of Sanofi-Aventis' Ketek
9 April 2007
MedImmune and Sanofi Pasteur in IP licensing accord
9 April 2007
Update on FDA review of Sanofi's rimonabant
2 April 2007
Iraq's Red Crescent demands $238M blood compensation
2 April 2007
Oxford and Sanofi in TroVax renal cancer deal
2 April 2007
"Le Fur flies" as Dehecq disagrees?
2 April 2007
S-P's TRA drug meets Ph II endpoints
2 April 2007
Presidential campaign trail for France's G5
2 April 2007
Sanofi's Acomplia gets French reimbursement
2 April 2007
Bogus Canadian web pharmacy's death probe
2 April 2007
Cannabinoid market forecast at over $700 million
26 March 2007
Stock Commentary - Europe - week to Mar 19
26 March 2007
Acambis loss down 43%, on Novartis deal
26 March 2007
France's LEEM co-opts four members
19 March 2007
Sanofi-Aventis reviews its "Access to Medicines" program
19 March 2007
Japan stock market week to March 12, 2007
19 March 2007
Lilly to buy Hypnion for access to drugs
12 March 2007
Poor 2006 for French drugmakers goes on
12 March 2007
Stock Commentary - Europe - week to March 5, 2007
12 March 2007
Patent grab could benefit Thai drug firm
12 March 2007
Sanofi-Aventis launches ASAQ in sub-Sahara
12 March 2007
Japan stock market week to March 5, 2007
12 March 2007
MNCs in Serbia move for "transparency"
12 March 2007
Zentiva buys into Hungarian market
12 March 2007
Sanofi's H5N1 vacc gets tentative US approval
5 March 2007
Taxotere's efficacy in prostate cancer shown
5 March 2007
Thailand's rulers extend "war" on patents
26 February 2007
Novacea's Asentar improves survival in AIPC
26 February 2007
Stock Commentary - Europe - week to Feb 19, 2007
26 February 2007
More controversy in Hungary over Rx-only
26 February 2007
US FDA warns about misrepresented drugs bought over the Internet
26 February 2007
GSK to sell off French production site
26 February 2007
Stock Commentary - New York week to Feb 12, 2007
19 February 2007
Stock Commentary - Europe - week to Feb 12, 2007
19 February 2007
Sanofi licenses Acambis JE vacc for Asia Pacific
19 February 2007
World vaccine market to exceed $15 billion in 2012
19 February 2007
Sanofi-Aventis' 4th-qtr profit falls 4.6%
19 February 2007
US FDA restricts use of Sanofi-Aventis' Ketek
19 February 2007
Thailand holds "final" talk with drugmakers
19 February 2007
Sanofi-Aventis loses US Lovenox patent case
19 February 2007
Stock Commentary - Europe - week to Feb 5, 2007
12 February 2007
Bush administration accused of "power grab"
12 February 2007
Hungarian pharma manufacturers call for conciliatory forum
12 February 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
